Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testing the Reliability and Validity of a New Measure for Illness-related Distress.

NCT06072287 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06072287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testing the Reliability and Validity of a New Measure for Illness-related Distress.
Lead sponsor
King's College London
Phase
Observational
Overall status
Unknown status
Start date
June 28, 2023
Completion date
January 10, 2024
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aids, arthritis, asthma, atrial fibrillation, cancer, celiac disease, cerebrovascular disorders, ckd, copd, cystic fibrosis, dementia, diabetes, eczema, endometriosis, epilepsy, fibromyalgia, heart disease chronic, heart diseases, heart failure, hepatitis, hidradenitis suppurativa, high blood pressure, hiv, hypertension, ibd, ibs, liver diseases, long covid, lupus erythematosus, me/cfs, migraine, mnd (motor neurone disease), multiple sclerosis, neurological disorder, obesity, osteoarthritis, osteoporosis, pain, parkinson disease, pcos, pots - postural orthostatic tachycardia syndrome, rheumatoid arthritis, sickle cell disease, spondylitis, stroke